Correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri and the sul genes
The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri (S. flexneri) and the antibiotic resistance genes sul1, sul2, and sul3 and SXT element.From May 2013 to October 2018, 102 isolates of S. flexneri were collected from the cli...
Saved in:
Published in | Medicine (Baltimore) Vol. 100; no. 10; p. e24970 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Lippincott Williams & Wilkins
12.03.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 0025-7974 1536-5964 1536-5964 |
DOI | 10.1097/MD.0000000000024970 |
Cover
Loading…
Abstract | The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri (S. flexneri) and the antibiotic resistance genes sul1, sul2, and sul3 and SXT element.From May 2013 to October 2018, 102 isolates of S. flexneri were collected from the clinical samples in Jinan. The Kirby-Bauer (K-B) test was employed to determine the antibiotic susceptibility of the S. flexneri isolates. The antibiotic resistance rate was analyzed with the WHONET5.4 software. The isolates were subject to the PCR amplification of the sul genes (sul1, sul2, and sul3) and the SXT element. On the basis of the sequencing results, the correlation between the sulfamethoxazole-trimethoprim resistance of the S. flexneri isolates and the sul genes was analyzed.The antibiotic resistance rates of the 102 S. flexneri isolates to ampicillin, streptomycin, chloramphenicol, tetracycline, and sulfamethoxazole-trimethoprim were 90.2%, 90.2%, 88.2%, 88.2%, and 62.7%, respectively. The antibiotic resistance rates of these isolates to cefotaxime, ceftazidime, and ciprofloxacin varied between 20% and 35%. However, these isolates were 100% susceptible to cefoxitin. Positive fragments were amplified from 59.8% (61/102) of the 102 S. flexneri isolates, the sizes of the sul1 and sul2 genes being 338 bp and 286 bp, respectively. The sequence alignment revealed the presence of the sul1 and sul2 genes encoding for dihydrofolate synthase. The carrying rate of the sul1 gene was 13.7% (14/102), and that of the sul2 gene was 48.0% (49/102). No target gene fragments were amplified from the 3 isolates resistant to sulfamethoxazole-trimethoprim. The sul3 gene and SXT element were not amplified from any of the isolates. The testing and statistical analysis showed that the resistance of the S. flexneri isolates to sulfamethoxazole-trimethoprim correlated to the sul1 and sul2 genes.The acquired antibiotic resistance genes sul1 and sul2 were closely associated with the resistance of the 102 S. flexneri isolates to sulfamethoxazole-trimethoprim. |
---|---|
AbstractList | The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of
Shigella flexneri
(
S. flexneri
) and the antibiotic resistance genes
sul1
,
sul2,
and
sul3
and
SXT element
.
From May 2013 to October 2018, 102 isolates of
S. flexneri
were collected from the clinical samples in Jinan. The Kirby–Bauer (K-B) test was employed to determine the antibiotic susceptibility of the
S. flexneri
isolates. The antibiotic resistance rate was analyzed with the WHONET5.4 software. The isolates were subject to the PCR amplification of the
sul
genes (
sul1
,
sul2
, and
sul3
) and the
SXT element
. On the basis of the sequencing results, the correlation between the sulfamethoxazole-trimethoprim resistance of the
S. flexneri
isolates and the
sul
genes was analyzed.
The antibiotic resistance rates of the 102
S. flexneri
isolates to ampicillin, streptomycin, chloramphenicol, tetracycline, and sulfamethoxazole-trimethoprim were 90.2%, 90.2%, 88.2%, 88.2%, and 62.7%, respectively. The antibiotic resistance rates of these isolates to cefotaxime, ceftazidime, and ciprofloxacin varied between 20% and 35%. However, these isolates were 100% susceptible to cefoxitin. Positive fragments were amplified from 59.8% (61/102) of the 102
S. flexneri
isolates, the sizes of the
sul1
and
sul2
genes being 338 bp and 286 bp, respectively. The sequence alignment revealed the presence of the
sul1
and
sul2
genes encoding for dihydrofolate synthase. The carrying rate of the
sul1
gene was 13.7% (14/102), and that of the
sul2
gene was 48.0% (49/102). No target gene fragments were amplified from the 3 isolates resistant to sulfamethoxazole-trimethoprim. The
sul3
gene and
SXT element
were not amplified from any of the isolates. The testing and statistical analysis showed that the resistance of the
S. flexneri
isolates to sulfamethoxazole-trimethoprim correlated to the
sul1
and
sul2
genes.
The acquired antibiotic resistance genes
sul1
and
sul2
were closely associated with the resistance of the 102
S. flexneri
isolates to sulfamethoxazole-trimethoprim. The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri (S. flexneri) and the antibiotic resistance genes sul1, sul2, and sul3 and SXT element.From May 2013 to October 2018, 102 isolates of S. flexneri were collected from the clinical samples in Jinan. The Kirby-Bauer (K-B) test was employed to determine the antibiotic susceptibility of the S. flexneri isolates. The antibiotic resistance rate was analyzed with the WHONET5.4 software. The isolates were subject to the PCR amplification of the sul genes (sul1, sul2, and sul3) and the SXT element. On the basis of the sequencing results, the correlation between the sulfamethoxazole-trimethoprim resistance of the S. flexneri isolates and the sul genes was analyzed.The antibiotic resistance rates of the 102 S. flexneri isolates to ampicillin, streptomycin, chloramphenicol, tetracycline, and sulfamethoxazole-trimethoprim were 90.2%, 90.2%, 88.2%, 88.2%, and 62.7%, respectively. The antibiotic resistance rates of these isolates to cefotaxime, ceftazidime, and ciprofloxacin varied between 20% and 35%. However, these isolates were 100% susceptible to cefoxitin. Positive fragments were amplified from 59.8% (61/102) of the 102 S. flexneri isolates, the sizes of the sul1 and sul2 genes being 338 bp and 286 bp, respectively. The sequence alignment revealed the presence of the sul1 and sul2 genes encoding for dihydrofolate synthase. The carrying rate of the sul1 gene was 13.7% (14/102), and that of the sul2 gene was 48.0% (49/102). No target gene fragments were amplified from the 3 isolates resistant to sulfamethoxazole-trimethoprim. The sul3 gene and SXT element were not amplified from any of the isolates. The testing and statistical analysis showed that the resistance of the S. flexneri isolates to sulfamethoxazole-trimethoprim correlated to the sul1 and sul2 genes.The acquired antibiotic resistance genes sul1 and sul2 were closely associated with the resistance of the 102 S. flexneri isolates to sulfamethoxazole-trimethoprim.ABSTRACTThe aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri (S. flexneri) and the antibiotic resistance genes sul1, sul2, and sul3 and SXT element.From May 2013 to October 2018, 102 isolates of S. flexneri were collected from the clinical samples in Jinan. The Kirby-Bauer (K-B) test was employed to determine the antibiotic susceptibility of the S. flexneri isolates. The antibiotic resistance rate was analyzed with the WHONET5.4 software. The isolates were subject to the PCR amplification of the sul genes (sul1, sul2, and sul3) and the SXT element. On the basis of the sequencing results, the correlation between the sulfamethoxazole-trimethoprim resistance of the S. flexneri isolates and the sul genes was analyzed.The antibiotic resistance rates of the 102 S. flexneri isolates to ampicillin, streptomycin, chloramphenicol, tetracycline, and sulfamethoxazole-trimethoprim were 90.2%, 90.2%, 88.2%, 88.2%, and 62.7%, respectively. The antibiotic resistance rates of these isolates to cefotaxime, ceftazidime, and ciprofloxacin varied between 20% and 35%. However, these isolates were 100% susceptible to cefoxitin. Positive fragments were amplified from 59.8% (61/102) of the 102 S. flexneri isolates, the sizes of the sul1 and sul2 genes being 338 bp and 286 bp, respectively. The sequence alignment revealed the presence of the sul1 and sul2 genes encoding for dihydrofolate synthase. The carrying rate of the sul1 gene was 13.7% (14/102), and that of the sul2 gene was 48.0% (49/102). No target gene fragments were amplified from the 3 isolates resistant to sulfamethoxazole-trimethoprim. The sul3 gene and SXT element were not amplified from any of the isolates. The testing and statistical analysis showed that the resistance of the S. flexneri isolates to sulfamethoxazole-trimethoprim correlated to the sul1 and sul2 genes.The acquired antibiotic resistance genes sul1 and sul2 were closely associated with the resistance of the 102 S. flexneri isolates to sulfamethoxazole-trimethoprim. The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri (S. flexneri) and the antibiotic resistance genes sul1, sul2, and sul3 and SXT element.From May 2013 to October 2018, 102 isolates of S. flexneri were collected from the clinical samples in Jinan. The Kirby-Bauer (K-B) test was employed to determine the antibiotic susceptibility of the S. flexneri isolates. The antibiotic resistance rate was analyzed with the WHONET5.4 software. The isolates were subject to the PCR amplification of the sul genes (sul1, sul2, and sul3) and the SXT element. On the basis of the sequencing results, the correlation between the sulfamethoxazole-trimethoprim resistance of the S. flexneri isolates and the sul genes was analyzed.The antibiotic resistance rates of the 102 S. flexneri isolates to ampicillin, streptomycin, chloramphenicol, tetracycline, and sulfamethoxazole-trimethoprim were 90.2%, 90.2%, 88.2%, 88.2%, and 62.7%, respectively. The antibiotic resistance rates of these isolates to cefotaxime, ceftazidime, and ciprofloxacin varied between 20% and 35%. However, these isolates were 100% susceptible to cefoxitin. Positive fragments were amplified from 59.8% (61/102) of the 102 S. flexneri isolates, the sizes of the sul1 and sul2 genes being 338 bp and 286 bp, respectively. The sequence alignment revealed the presence of the sul1 and sul2 genes encoding for dihydrofolate synthase. The carrying rate of the sul1 gene was 13.7% (14/102), and that of the sul2 gene was 48.0% (49/102). No target gene fragments were amplified from the 3 isolates resistant to sulfamethoxazole-trimethoprim. The sul3 gene and SXT element were not amplified from any of the isolates. The testing and statistical analysis showed that the resistance of the S. flexneri isolates to sulfamethoxazole-trimethoprim correlated to the sul1 and sul2 genes.The acquired antibiotic resistance genes sul1 and sul2 were closely associated with the resistance of the 102 S. flexneri isolates to sulfamethoxazole-trimethoprim. |
Author | Yao, Mingxiao Sun, Yuguo Yuan, Guangying Ma, Quanping Zhu, Chengbao |
AuthorAffiliation | Department of Clinical Laboratory, Jinan Infectious Disease Hospital Affiliated to Shandong University Department of Clinical Laboratory, The Fourth People's Hospital of Jinan Department of Viral Infectious Diseases Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan |
AuthorAffiliation_xml | – name: Department of Clinical Laboratory, Jinan Infectious Disease Hospital Affiliated to Shandong University – name: Department of Clinical Laboratory, The Fourth People's Hospital of Jinan – name: Department of Viral Infectious Diseases Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan – name: d Collaborative Innovation Center for the Origin and Control of Emerging Infectious Diseases, Taishan Medical University, Taian, Shandong Province 271016, China – name: a Department of Clinical Laboratory, The Fourth People's Hospital of Jinan – name: c Department of Viral Infectious Diseases Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan – name: b Department of Clinical Laboratory, Jinan Infectious Disease Hospital Affiliated to Shandong University |
Author_xml | – sequence: 1 givenname: Quanping surname: Ma fullname: Ma, Quanping organization: Department of Clinical Laboratory, The Fourth People's Hospital of Jinan – sequence: 2 givenname: Chengbao surname: Zhu fullname: Zhu, Chengbao organization: Department of Clinical Laboratory, Jinan Infectious Disease Hospital Affiliated to Shandong University – sequence: 3 givenname: Mingxiao surname: Yao fullname: Yao, Mingxiao organization: Department of Viral Infectious Diseases Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan – sequence: 4 givenname: Guangying surname: Yuan fullname: Yuan, Guangying organization: Department of Clinical Laboratory, Jinan Infectious Disease Hospital Affiliated to Shandong University – sequence: 5 givenname: Yuguo surname: Sun fullname: Sun, Yuguo organization: Department of Clinical Laboratory, The Fourth People's Hospital of Jinan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33725864$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UctuFDEQtFAQ2QS-AAnNkcsEv2Y8viChDS8pEQfgbDme9o7Bawfbw4Z8fby7WR454Eu521XV7e4TdBRiAISeE3xGsBSvLs_P8J9DuRT4EVqQjvVtJ3t-hBY127VCCn6MTnL-hjFhgvIn6JhV7IaeL9BqGVMCr4uLobmCsgEITZmgybO3eg1lijf6NnpoS3K78LpikyC7XHQw0ETbfJ7cCrzXjfVwEyC5Rofx4NKsIEB-ih5b7TM8u8dT9PXd2y_LD-3Fp_cfl28uWsM7PLSmdowNgbGT0o49ED5Yy_qxN0ywQYih3s2AqeVUgrEU855rNowEKDOGYXaKXu99r-erNYwGQknaq23TOv1SUTv170twk1rFn0rIXlIpq8HLe4MUf8yQi1q7bLa_CxDnrGp_lOK-jrZSX_xd63eRw3QrQe4JJsWcE1hlXNmNupZ2XhGstptUl-fq4Sarlj3QHuz_r-J71Sb6Ail_9_MGkppA-zLt6J2QtKWYEswIxe02M7A7eY2xwg |
CitedBy_id | crossref_primary_10_3390_antibiotics11111531 crossref_primary_10_3389_fmicb_2023_1192769 crossref_primary_10_1007_s10123_023_00472_9 crossref_primary_10_3390_applmicrobiol4040102 crossref_primary_10_1089_fpd_2023_0118 crossref_primary_10_3390_ani12080976 crossref_primary_10_1089_fpd_2023_0138 |
Cites_doi | 10.1016/S1473-3099(17)30276-1 10.1128/jb.178.14.4157-4165.1996 10.1371/journal.pone.0195259 10.1099/jmm.0.46655-0 10.1371/journal.pone.0112626 10.1093/jac/dki332 10.1128/AAC.00652-07 10.1007/s10482-016-0716-3 10.1128/AAC.00800-08 10.1016/j.fm.2013.12.001 10.1016/j.ijmm.2015.04.005 10.1038/383219a0 10.1128/AAC.01748-17 10.1128/AAC.47.3.1169-1172.2003 10.1093/jac/dkg426 10.1016/j.ijantimicag.2018.02.005 10.1186/1751-0147-52-47 10.3389/fmicb.2016.01896 10.1054/drup.2000.0146 10.1371/journal.pone.0085338 10.1186/s12941-019-0321-1 10.1016/j.jgar.2018.10.014 |
ContentType | Journal Article |
Copyright | Lippincott Williams & Wilkins Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 |
Copyright_xml | – notice: Lippincott Williams & Wilkins – notice: Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. – notice: Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1097/MD.0000000000024970 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1536-5964 |
EndPage | e24970 |
ExternalDocumentID | PMC7969299 33725864 10_1097_MD_0000000000024970 00005792-202103120-00058 |
Genre | Journal Article |
GroupedDBID | --- .-D .XZ .Z2 01R 0R~ 354 40H 4Q1 4Q2 4Q3 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAGIX AAHPQ AAIQE AAMOA AAQKA AARTV AASCR AAWTL AAXQO AAYEP ABASU ABBUW ABCQX ABDIG ABFRF ABOCM ABVCZ ABXVJ ABZAD ABZZY ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADGGA ADHPY ADNKB ADPDF AE6 AEFWE AENEX AFBFQ AFDTB AGOPY AHOMT AHQNM AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BQLVK CS3 DIWNM DU5 E.X EBS EEVPB ERAAH EX3 F2K F2L F2M F2N F5P FCALG FD6 FIJ FL- GNXGY GQDEL GROUPED_DOAJ H0~ HLJTE HYE HZ~ H~9 IKREB IKYAY IN~ IPNFZ JK3 JK8 K8S KD2 KMI KQ8 L-C N9A N~7 N~B O9- OAG OAH OB2 OHH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH OUVQU OVD OVDNE OVEED OVIDH OVLEI OWV OWW OWZ OXXIT P2P RIG RLZ RPM RXW S4R S4S TAF TEORI TSPGW UNMZH V2I VVN W3M WOQ WOW X3V X3W XYM YFH YOC ZFV ZY1 AAYXX CITATION 8L- ACIJW AWKKM CGR CUY CVF ECM EIF NPM ODA 7X8 ADSXY 5PM |
ID | FETCH-LOGICAL-c4508-c0250c1ed599fd6e148ff36d6c373877836dc802f429ecf20464a38d1e23cc303 |
ISSN | 0025-7974 1536-5964 |
IngestDate | Thu Aug 21 18:42:13 EDT 2025 Fri Sep 05 14:31:14 EDT 2025 Wed Feb 19 02:24:43 EST 2025 Tue Jul 01 05:08:46 EDT 2025 Thu Apr 24 23:12:56 EDT 2025 Fri May 16 03:51:08 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
License | Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4508-c0250c1ed599fd6e148ff36d6c373877836dc802f429ecf20464a38d1e23cc303 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-2095-1781 |
OpenAccessLink | http://dx.doi.org/10.1097/MD.0000000000024970 |
PMID | 33725864 |
PQID | 2502206002 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7969299 proquest_miscellaneous_2502206002 pubmed_primary_33725864 crossref_citationtrail_10_1097_MD_0000000000024970 crossref_primary_10_1097_MD_0000000000024970 wolterskluwer_health_00005792-202103120-00058 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20210312 2021-03-12 2021-Mar-12 |
PublicationDateYYYYMMDD | 2021-03-12 |
PublicationDate_xml | – month: 03 year: 2021 text: 20210312 day: 12 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hagerstown, MD |
PublicationTitle | Medicine (Baltimore) |
PublicationTitleAlternate | Medicine (Baltimore) |
PublicationYear | 2021 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
References | Lluque (R17-20250504) 2015; 305 Muthuirulandi Sethuvel (R19-20250504) 2019; 16 Hussen (R12-20250504) 2019; 18 Mamishi (R18-20250504) 2019; 31 Rodríguez-Blanco (R27-20250504) 2016; 109 Byrne-Bailey (R25-20250504) 2009; 53 Binet (R11-20250504) 2014; 40 Mohd (R20-20250504) 2014; 9 Yunmin (R16-20250504) 2016; 16 Badhai (R28-20250504) 2016; 7 Waldor (R26-20250504) 1996; 178 Aarestrup (R9-20250504) 2003; 52 Kotloff (R3-20250504) 1999; 77 Liu (R15-20250504) 2018; 13 Bean (R24-20250504) 2005; 56 Vubil (R21-20250504) 2018; 51 Ramachandran (R10-20250504) 2007; 56 Sköld (R5-20250504) 2000; 3 (R1-20250504) 2017; 17 Wu (R22-20250504) 2010; 52 Perreten (R6-20250504) 2003; 47 Darton (R13-20250504) 2018; 62 Bean (R23-20250504) 2009; 53 Waldor (R7-20250504) 1996; 178 Davies (R2-20250504) 1996; 383 Wang (R14-20250504) 2014; 9 |
References_xml | – volume: 17 start-page: 909 year: 2017 ident: R1-20250504 article-title: Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(17)30276-1 – volume: 178 start-page: 4157 year: 1996 ident: R7-20250504 article-title: A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139 publication-title: J Bacteriol doi: 10.1128/jb.178.14.4157-4165.1996 – volume: 13 start-page: e0195259 year: 2018 ident: R15-20250504 article-title: Dominant serotype distribution and antimicrobial resistance profile of Shigella spp. in Xinjiang, China publication-title: PLoS One doi: 10.1371/journal.pone.0195259 – volume: 56 start-page: 346 year: 2007 ident: R10-20250504 article-title: Multiplex PCR for detection of antibiotic resistance genes and the SXT element: application in the characterization of Vibrio cholerae[J] publication-title: J Med Microbiol doi: 10.1099/jmm.0.46655-0 – volume: 9 start-page: e112626 year: 2014 ident: R14-20250504 article-title: Sulfonamide-resistant bacteria and their resistance genes in soils fertilized with manures from Jiangsu Province, Southeastern China publication-title: PLoS One doi: 10.1371/journal.pone.0112626 – volume: 56 start-page: 962 year: 2005 ident: R24-20250504 article-title: Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man publication-title: J Antimicrob Chemother doi: 10.1093/jac/dki332 – volume: 53 start-page: 697 year: 2009 ident: R25-20250504 article-title: Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00652-07 – volume: 178 start-page: 4157 year: 1996 ident: R26-20250504 article-title: A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139 publication-title: J Bacteriol doi: 10.1128/jb.178.14.4157-4165.1996 – volume: 109 start-page: 1141 year: 2016 ident: R27-20250504 article-title: Unveiling the pan-genome of the SXT/R391 family of ICEs: molecular characterisation of new variable regions of SXT/R391-like ICEs detected in Pseudoalteromonas sp. and Vibrio scophthalmi publication-title: Antonie van uwenhoek doi: 10.1007/s10482-016-0716-3 – volume: 53 start-page: 1088 year: 2009 ident: R23-20250504 article-title: Plasmids imparting sulfonamide resistance in Escherichia coli: implications for persistence publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00800-08 – volume: 40 start-page: 48 year: 2014 ident: R11-20250504 article-title: Rapid detection of Shigella and enteroinvasive Escherichia coli in produce enrichments by a conventional multiplex PCR assay publication-title: Food Microbiol doi: 10.1016/j.fm.2013.12.001 – volume: 305 start-page: 480 year: 2015 ident: R17-20250504 article-title: Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru) publication-title: Int J Med Microbiol doi: 10.1016/j.ijmm.2015.04.005 – volume: 383 start-page: 219 year: 1996 ident: R2-20250504 article-title: Bacteria on the rampage publication-title: J Nature doi: 10.1038/383219a0 – volume: 62 start-page: e01748-17 year: 2018 ident: R13-20250504 article-title: Azithromycin resistance in Shigella spp. in Southeast Asia publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01748-17 – volume: 47 start-page: 1169 year: 2003 ident: R6-20250504 article-title: A new sulfonamide resistance gene (sul3) in Escherichia coli is widespread in the pig population of Switzerland publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.47.3.1169-1172.2003 – volume: 77 start-page: 651 year: 1999 ident: R3-20250504 article-title: Global burden of Shigella infections: implications for vaccine development and implementation of control strategies publication-title: Bull World Health Organ – volume: 52 start-page: 715 year: 2003 ident: R9-20250504 article-title: Antimicrobial susceptibility and occurrence of resistance genes among Salmonella enterica serovar Weltevreden from different countries publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkg426 – volume: 51 start-page: 881 year: 2018 ident: R21-20250504 article-title: Antibiotic resistance and molecular characterization of shigella isolates recovered from children aged less than 5 years in Manhiça, Southern Mozambique publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2018.02.005 – volume: 52 start-page: 47 year: 2010 ident: R22-20250504 article-title: Prevalence and characterization of plasmids carrying sulfonamide resistance genes among Escherichia coli from pigs, pig carcasses and human publication-title: Acta Vet Scand doi: 10.1186/1751-0147-52-47 – volume: 7 start-page: 1896 year: 2016 ident: R28-20250504 article-title: Characterization of three novel SXT/R391 integrating conjugative elements ICEMfulnd1a and ICEMfulnd1b, and ICEMprChn1 identified in the genomes of Marinomonas fungiae JCM 18476T and Marinomonas profundimaris Strain D104 publication-title: Front Microbiol doi: 10.3389/fmicb.2016.01896 – volume: 3 start-page: 155 year: 2000 ident: R5-20250504 article-title: Sulfonamide resistance: mechanisms and trends publication-title: Drug Resist Updat doi: 10.1054/drup.2000.0146 – volume: 9 start-page: e85338 year: 2014 ident: R20-20250504 article-title: Plasmid-mediated sulfamethoxazole resistance encoded by the sul2 gene in the multidrug-resistant Shigella flexneri 2a isolated from patients with acute diarrhea in Dhaka, Bangladesh publication-title: PLoS One doi: 10.1371/journal.pone.0085338 – volume: 31 start-page: 356 year: 2019 ident: R18-20250504 article-title: Antimicrobial-resistance pattern of Shigella species in children: a six-year study in an Iranian referral Hospital publication-title: Ann Ig – volume: 16 start-page: 160 year: 2016 ident: R16-20250504 article-title: CHINET Shigella resistance surveillance from 2005 to 2014 publication-title: Chin J Infect Chemother – volume: 18 start-page: 22 year: 2019 ident: R12-20250504 article-title: Prevalence of Shigella species and its drug resistance pattern in Ethiopia: a systematic review and meta-analysis publication-title: Ann Clin Microbiol Antimicrob doi: 10.1186/s12941-019-0321-1 – volume: 16 start-page: 215 year: 2019 ident: R19-20250504 article-title: IncFII plasmid carrying antimicrobial resistance genes in Shigella flexneri: vehicle for dissemination publication-title: J Glob Antimicrob Resist doi: 10.1016/j.jgar.2018.10.014 |
SSID | ssj0013724 |
Score | 2.3883698 |
Snippet | The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri (S. flexneri) and the antibiotic... The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri ( S. flexneri ) and the... |
SourceID | pubmedcentral proquest pubmed crossref wolterskluwer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e24970 |
SubjectTerms | Bacterial Proteins - genetics Carrier Proteins - genetics DNA Transposable Elements - genetics DNA, Bacterial - genetics DNA, Bacterial - isolation & purification Dysentery, Bacillary - drug therapy Dysentery, Bacillary - microbiology Feces - microbiology Humans Microbial Sensitivity Tests Observational Study Polymerase Chain Reaction Shigella flexneri - drug effects Shigella flexneri - genetics Shigella flexneri - isolation & purification Trimethoprim Resistance - genetics Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use |
Title | Correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri and the sul genes |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005792-202103120-00058 https://www.ncbi.nlm.nih.gov/pubmed/33725864 https://www.proquest.com/docview/2502206002 https://pubmed.ncbi.nlm.nih.gov/PMC7969299 |
Volume | 100 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLagk6ZJCHGnXCYj8TYCqdNc_Ahr0YRUENKG9hY5jp1VlKSiiSj79Zxjx2lKxwT0IW2d1HH6fXHO8bkR8jLLmQD9RntS56CgYPJZwWPuBTzxcxXJXBgL_uxjdHI2_nAenm9WlUx0SZ29lpdXxpX8D6rQBrhilOw_INt1Cg3wGfCFLSAM27_C-BhLa1hnts7hCgXJVbPQwtSGXovLaqG8GpP4w9clvB-Bgo1CI97RGLFyMS_QA-pIL9S6hFF3PpXQCxZYbp0MXdWn1haPkuk7sajn1lG3W06YGWH0cyPKpXsommXpxtr2VVlkouqmGlFZ1_2yWM97zY1dlQX6lsVP1027NMGMb1brFK3cdBp5Ibd5yrv51vf7xPJ706cCZdDWEdmZ2W3G4NnEJpy0r52jAZ7lNwN2EMQsTNoTbyfUdrtukj0GuoU_IHufvkynk43xKWZjl6CKx2-uOOcB2Xe9bMszO0rKrq_trR8V-kGsvpowiJ4wc3qH3G61EPrWUuouuaHKe2TfYXufFD1m0ZZZFDhBr2UW3TCLVpo6ZlHHLArMcr1Qw6wH5Oz99PT4xGtLcnhyDKK8J1FkliOVh5zrPFKgTGsdRHkkMUNWjCFBuUx8pkHMUVIzNJyLIMlHigVSgrj0kAzKqlSPCZURqLZKcBVxNo5UJvJEjTI1zgKQwkOth4S5PzaVbb56LJuySJ3fxGyS_g7MkLzqfrS06VquP_yFQyyFaRVtZaJUVbNK4TIZ89FoPSSPLIJdhw76IYm3sO0OwJTt23vK-YVJ3R5zuFrOh8TbYkFqg57N-MKYMw_vJnjcMpP1IUye_HEMT8nB5s57Rgb190Y9BzG5zg7N8tJhS-5fnrO8iQ |
linkProvider | Ovid |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9NAFB60CyqIeDdeR5A8GW0nySTz0IfSZq3rpgrtuutTmMylu1iSYltd_PWek0vduijYl7RkEkjnJPOdnO98HyGvcs0k5DfWU1ZDgoLis1JEwvNF3NWGKy2rCn464eOj4OAkPGnYFtgLg91nq-Ub3FTPafyCfjiYGM76B1N3khxP-4U7nA77X9xPg3dJ9Z4aWRLuqF9-t2t3MKn4V2EkGMQAQx8DVnVPh_FVssdR36RD9j5-TpLR73pDxIKtuStA7FafSERv01GtcVh_IFtBX-OLa9glYHqZX3nzR4m179XXivp-YQHbv01uNciTDupQuUOumOIuuZY2tfV7ZD5Eo46aGkcb-hYFeEhXm4WVldP0ufxZLoy3RksA-LmELYV0HSEoxA4tLZ2ens2RT0XtwpwXEN1UFro9C53jg_U-OdpPZsOx19gweCoA-OYphEmqZ3QohNXcQAJlrc81V6iKFGEbiFZxl1lY2oyyDIul0o91zzBfKVgiH5BOURbmEaGKQzpjpDAc0j5ucqlj08tNkPuAvEJrHcLaPzZTjUY5WmUssrZWno6yP2fDIa-3By1riY5_D3_ZzlgGtxLWR2Rhys0qg8tkrIuFSoc8rGdwe0IfIiSMeeCQaGdutwNQpnt3T3F2Wsl1RwKuVgiHeDtRkNWNrtnfYvXxf45_Qa6PZ-lhdvh-8uEJuYF7kSvXY09JZ_1tY54BeFrnz5vI_wV6Kg8w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLamTpqQEOK-cDUSyhNBrZM48UMepiZlDNpN6gbjKXJ86SaqpKItDH495-RSKENI9CWt4lpNfWJ_J9_x9xHystBMQn5jPWU1JCgoPitFJDxfxH1tuNKyZvDHE354Fhydh-c7pGNMcfPZcvEaD_U0jW_QDgfzwtPkaOoOp8PkkzvJPk6TiXty8CarH1NjkYR7ko6S726aVF_tyk2Pk06fcZw2IoXNC9KNCFL83RjNl3pk9_hDlqW_eIeIBRuTV4DanU7R37vZXsuuAdTrdZY3v1XIgS8_1yXwvy1ko9vkVotA6UETMnfIjinvkr1xy7HfI7MhGnY0JXK0LeOiABPpcj23snacvpI_qrnxVmgNAB8XcKSQtiMUhRiilaXTi8sZ1lVROzdXJUQ5laXueqEznGDvk7NRdjo89Fo7Bk8FAOM8hXBJDYwOhbCaG0ikrPW55grVkSLcDqJV3GcWljijLEPSVPqxHhjmKwVL5QPSK6vS7BOqOKQ1RgrDIf3jppA6NoPCBIUPCCy01iGs-2Nz1WqVo2XGPO8483Ga_zkaDnm1-dKiker4d_MX3YjlcEshTyJLU62XOVwmY30kLB3ysBnBTYc-REgY88Ah0dbYbhqgXPf2mfLyopbtjgRcrRAO8baiIG82vNa_L4wEg3mLofcGq3f8h_Gj_2z_nOzBnZC_fzt595jcwJNYMjdgT0hv9WVtngKGWhXP2sD_CZE4ELs |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correlation+between+the+sulfamethoxazole-trimethoprim+resistance+of+Shigella+flexneri+and+the+sul+genes&rft.jtitle=Medicine+%28Baltimore%29&rft.au=Ma%2C+Quanping&rft.au=Zhu%2C+Chengbao&rft.au=Yao%2C+Mingxiao&rft.au=Yuan%2C+Guangying&rft.date=2021-03-12&rft.eissn=1536-5964&rft.volume=100&rft.issue=10&rft.spage=e24970&rft_id=info:doi/10.1097%2FMD.0000000000024970&rft_id=info%3Apmid%2F33725864&rft.externalDocID=33725864 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7974&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7974&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7974&client=summon |